Hypotheses regarding the mechanisms of ayahuasca in the treatment of addictions

Journal of Psychoactive Drugs

Volumn 44, Issue 3, 2012, Pages 200-208

  Liester, Mitchell B ^a   Prickett, James I ^b  

^a University of Arizona ^*  (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Addiction; Ayahuasca; Mesolimbic pathway; Monoamine oxidase inhibitors; N; N dimethyltryptamine (DMT); Transcendent experience

Indexed keywords

EID: 84868100533     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2012.704590     Document Type: Article

References (48)

1. Benaliouad, F.; Kapur, S.; & Rompre, P.P. 2006. Blockade of 5- HTa receptors reduces haloperidol-induced attenuation of reward. Neuropsychopharmacology 32 (3): 551-61.
2. Berke, J.D. & Hyman, S.E. 2000. Addiction, dopamine, and the molecular mechanisms of memory. Neuron 25: 515-32.
3. Beyer, S.V. 2009. Singing to the Plants: A Guide to Mestizo Shamanism in the Upper Amazon. Albuquerque: University of New Mexico Press.
4. Busch, A.K. & Johnson, W.C. 1950. L.S.D. 25 as an aid in psychotherapy. Disease of the Nervous System 11: 241-43.
5. Callaway, J.C.; McKenna, D.J.; Grob, C.S.; Brito, G.S.; Raymon, L.P.; Poland, R.E.; Andrade, E.N.; Andrade, E.O. & Mash, D.C. 1999. Pharmacology of Hoasca alkaloids in healthy humans. Journal of Ethnopharmacology 65 (3): 243-56.
6. Callaway, J.C.; Airaksinen, M.M.; McKenna, D.J.; Brito, G.S. & Grob, C.S. 1994. Platelet serotonin uptake sites increased in drinkers of ayahuasca. Psychopharmacology 116: 385-87.
7. Carvalho, R.C; Fukushiro, D.F.; Helfer, D.C.; Callefaro-Filho, D.; Trombin, T.F.; Zanlorenci, L.H.; Sanday, l.: Sivla, R.H.; & Frussa-Filho, R. 2009. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice; role of dopamine D2 receptors. Addiction Biology 14 (3): 283-93.
8. Celeste, E. 2010. Potent jungle vine brew has potential to treat addiction. Voice of America. Available at http://www.voanews.com/english/news/health/Potent-Jungle-Vine-Brew-Has-Potential-to-Treat-Addiction-88923322.html.
9. dos Santos, R.G.; Valle, M.; Bouso, J.C.; Nomdedeu, J.F.; Rodriguez- Espinosa, J.; McIlhenny, E.H.; Barker, S.A.; Barbanoj, M.J.; Riba, J. 2011. Autonomic, neuroendocrine, and immunological effects of ayahuasca: A comparative study with D-amphetamine. Journal of Clinical Psychopharmacology 31: 1-10.
10. Glennon, R.A.; Dukat, M.; Grella, B.; Hong, S.; Costantino, L.; Teitler, M.; Smith, C.; Egan, C.; Davis, K. & Mattson, M.V. 2000. Binding of β-carbolines and related agents at serotonin (5-HT2 and 5-HT1A), dopamine (D2) and benzodiazepine receptors. Drug and Alcohol Dependence 60 (2): 121-32.
11. Grof, S. 2008. LSD Psychotherapy. Ben Lomond, CA: Multidisciplinary Association for Psychedelic Studies.
12. Grob, C.S. (Ed.) 2002. Hallucinogens: A Reader. New York: Jeremy P. Tarcher/Putnam.
13. Guerra, F. 1971. The Pre-Columbian Mind. London: Seminar Press.
14. Harner, M. 1973. Hallucinogens and Shamanism. New York: Oxford University Press.
15. Hoffer, A. 1970. Treatment of alcoholism with psychedelic therapy. In: B. Aaronson & H. Osmond (Eds.) Psychedelics: The Uses and Implications of Psychedelic Drugs. New York: Doubleday & Company.
16. Hoffer, A. & Osmond, H. 1967. The Hallucinogens. New York: Academic Press.
17. Hofmann, A. 2009. LSD: My Problem Child. Santa Cruz, CA: Multidisciplinary Association for Psychedelic Studies.
18. Hollister, L.E. 1962. Drug-induced psychoses and schizophrenic reactions. Annals of the New York Academy of Sciences 96: 80-88.
19. Huxley, A. 1977. Doors of Perception: Heaven and Hell. New York: HarperCollins.
20. Kampman, K.M.; Pettinati, H.M.; Lynch, K.G.; Whittingham, T.; Macfadden, W.; Dackis, C.; Tirado, C.; Oslin, D.W.; Sparkman, T. & O'Brien, C.P. 2007. A double-blind, placebo controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism. Journal of Clinical Psychopharmacology 27 (4): 344-51.
21. Labate, B.C.; Santana de Rose, I. & Guimaraes dos Santos, R. 2008. Ayahuasca Religions: A Comprehensive Bibliography & Critical Essays. Santa Cruz, CA: Multidisciplinary Association of Psychedelic Studies.
22. Mabit, J. 2007. Ayahuasca in the treatment of addictions. In: T.B. Robert &M.J.Winkelman (Eds.) Psychedelic Medicine. Vol. 2: New Evidence for Hallucinogenic Substances as Treatments. Westport, CT: Praeger.
23. Mabit, J. 1996. Takiwasi: Ayahuasca and shamanism in addiction therapy. Newsletter for the Multidisciplinary Association for Psychedelic Studies 6 (3): 24-31.
24. Mameli, M. & Luscher, C. 2011. Synaptic plasticity and addiction: Learning mechanisms gone awry. Neuropharmacology 61 (7): 1052-59.
25. Mangini, M. 1998. Treatment of alcoholism using psychedelic drugs: A review of the program of research. Journal of Psychoactive Drugs 30 (4): 381-418.
26. Martinotti, G.; Andreoli, S.; Di Nicola, M.; Di Giannantonio, M.; Sarchiapone, M.; & Janiri, L. 2008. Quetiapine decreses alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics. Human Psychopharmacology 23 (5): 417-24.
27. Matthews, A.M.; Wilson, V.B. & Mitchell, S.H. 2011. The role of antipsychotics in smoking and smoking cessation. CNS Drugs 25 (4): 299-315.
28. McKenna, D.J.; Callaway, J.C. & Grob, C.S. 1998. The scientific investigation of ayahuasca: A review of past and current research. Heffter Review of Psychedelic Research 1: 65-76.
29. McKenna, D.J.; Towers, G.H.N. & Abbott, F. 1984. Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and B-carobline constituents of ayahuasca. Journal of Ethnopharmacology 10: 195-223.
30. Metzner, R. 2006. Sacred Vine of Spirits: Ayahuasca. Rochester, VT: Inner Traditions.
31. Morris, K. 2007. Research on psychedelics moves into the mainstream. Lancet 371: 1491-92.
32. Naranjo, P. 1986. El ayahuasca in la arqueologia ecuatoriana. America Indigena 46: 117-28.
33. Osmond, H. 1957. A review of the clinical effects of psychotomimetic agents. Annals of the New York Academy of Sciences 66: 418-34.
34. Pahnke, W. 1963. Drugs and mysticism: An analysis of the relationship between psychedelic drugs and the mystical consciousness. Ph.D. dissertation, Harvard University.
35. Pierce, R.C. & Kumaresan, V. 2006. The mesolimbic dopamine system: The final common pathway for the reinforcing effect of drugs of abuse? Neuroscience and Biobehavioral Reviews 30: 216-38.
36. Ratsch, C. 2005. The Encyclopedia of Psychoactive Plants: Enthnopharmacology and Its Applications. Rochester, VT: Inner Traditions.
37. Ray, L.A.; Heydari, A.; & Zorick, T. 2010. Quetiapine for the treatment of alcoholism: Scientific rationale and review of the literature. Drug and Alcohol Review 29 (5): 568-75.
38. Riba, J.; Rodriguez-Fornells, A.; Urbano, G.; Morte, A.; Antonijoan, R.; Montero, M.; Callaway, J.C. & Barbanoj, M.J. 2001. Subjective effects and tolerability of the South American psychoactive beverage ayahuasca in healthy volunteers. Psychopharmacology 154: 85-95.
39. Saal, D.; Dong, Y.; Bonci, A. & Malenka, R.C. 2003. Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 37 (4): 577-82.
40. Schultes, R.E. 1982. The beta-carboline hallucinogens of South America. Journal of Psychoactive Drugs 14: 205-19.
41. Schultes, R.E.; Hofmann, A. & Ratsch, C. 1998. Plants of the Gods: Their Sacred, Healing, and Hallucinogenic Powers. Rochester, VT: Healing Arts Press.
42. Shulgin, A. & Shulgin, A. 1997. Tihkal, the Continuation. Berkeley, CA: Transform Press.
43. Slotkin, J.S. 1956. The Peyote Religion. Glenco, IL: Free Press.
44. Stahl, S.M. 2008. Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. Cambridge, NY: Cambridge University Press.
45. Strassman, R. 2001. DMT: The Spirit Molecule. Rochester, VT: Park Street Press.
46. Tost, H.; Braus, D.F.; Hakimi, S.; Ruf, M.; Vollmlert, C.; Hohn, F. & Meyer-Lindenberg, A. 2010. Acute D2 receptor blockade induces rapid, reversible remodeling in human cortical-striatal circuits. Nature Neuroscience 13 (8): 920-22.
47. Wilson, W. 1994. The society of Alcoholics Anonymous. American Journal of Psychiatry. Supplement, 151: 259-262. Read at the 105th annual meeting of the American Psychiatric Association, Montreal, Quebec, May 23-27, 1949.
48. Yamberla, R. (Mr. Yamberla is a fourth generation practitioner of Natural Medicine from Iluman, Ecuador. He has extensive training and experience with the traditional use of ayahuasca. He now lives in Santa Fe, New Mexico.) 2010. Personal communication.